1. The dry-coated tablet, comprising: an inner core comprising, as active ingredients (a) tegafur, (b) gimeracil and (c) oteracil potassium ivneshnyuyu obolochku.2. . Dry-coated tablet according to claim 1 which comprises (a) tegafur, (b) gimeracil and (c) oteracil potassium in a molar ratio of 1: 0.4: 1.3. Dry-coated tablet according to Claim. 1 or 2, wherein the active ingredients consist of (a) tegafur, (b) gimeracil and (c) oteracil potassium is 50 wt%. to 100% by weight. by weight of the components internal yadra.4. Dry-coated tablet according to Claim. 1, wherein the active ingredients consist of (a) tegafur, (b) gimeracil and (c) oteracil potassium is 70 wt%. to 99% wt. by weight of the components internal yadra.5. Dry-coated tablet according to claim 1, wherein the total content of active ingredients (a) -. (C) is from 10 to 60% by weight. by weight of the dry coated method tabletki.6. Dry-coated tablet according to Claim. 1, wherein the outer shell comprises one, two or three compounds of lactose, crystalline cellulose and gidroksipropiltsellyulozy.7. Dry-coated tablet according to claim. 6 where the outer shell comprises one or two compounds from lactose and crystalline tsellyulozy.8. Dry-coated tablet according to claim. 7 wherein the outer shell comprises lactose and crystalline tsellyulozu.9. Dry-coated tablet according to claim. 6, 7 or 8, wherein the outer shell further comprises dezintegrant.10. Dry-coated tablet according to claim. 9, wherein the disintegrant is selected from the group consisting of crospovidone, carmellose, corn starch, hydroxypropyl cellulose with a low degree of substitution and partly pregelatinized krahmala.11. cover1. Покрытая сухим способом таблетка, содержащая:внутреннее ядро, содержащее в качестве активных ингредиентов (a) тегафур, (b) гимерацил и (c) отерацил калия, ивнешнюю оболочку.2. Покрытая сухим способом таблетка по п. 1, которая содержит (a) тегафур, (b) гимерацил и (c) отерацил калия в молярном отношении 1:0,4:1.3.
